focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,026.00
Bid: 2,024.00
Ask: 2,028.00
Change: -2.00 (-0.10%)
Spread: 4.00 (0.198%)
Open: 2,030.00
High: 2,034.00
Low: 2,022.00
Prev. Close: 2,028.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS: Merill Lynch Cuts Tesco To Underperform

Mon, 17th Mar 2014 10:07

LONDON (Alliance News) - The following UK shares received analyst recommendations Monday morning:
----------
FTSE 100
----------
BERENBERG CUTS SSE PRICE TARGET TO 1320 (1570) PENCE - 'HOLD'
----------
BERENBERG CUTS REED ELSEVIER TO 'HOLD' ('BUY') - TARGET 930 (895) PENCE
----------
MERRILL LYNCH CUTS TESCO TO 'UNDERPERFORM' ('NEUTRAL')
----------
NOMURA RAISES BURBERRY PRICE TARGET TO 1650 (1630) PENCE - 'NEUTRAL'
----------
CREDIT SUISSE RAISES SHELL PRICE TARGET TO 2450 (2350) PENCE - 'OUTPERFORM'
----------
CITIGROUP RAISES WOLSELEY PRICE TARGET TO 3660 (3596) PENCE - 'BUY'
----------
EXANE BNP RAISES ASTRAZENECA PRICE TARGET TO 3500 (3200) PENCE - 'NEUTRAL'
----------
EXANE BNP RAISES SHIRE PRICE TARGET TO 3600 (3100) PENCE - 'OUTPERFORM'
----------
Jefferies Raises Next Price Target To 7,500p From 7,000p - Buy
----------
LIBERUM CUTS WPP PRICE TARGET TO 1280 (1600) PENCE - 'HOLD'
----------
BARCLAYS RAISES STANDARD LIFE PRICE TARGET TO 377 (349) PENCE - 'EQUAL WEIGHT'
----------
FTSE 250
----------
BARCLAYS RAISES MICRO FOCUS TO 'OVERWEIGHT' ('EQUAL WEIGHT')
----------
CITIGROUP CUTS BWIN.PARTY TO 'SELL' ('NEUTRAL') - TARGET 95 (125) PENCE
----------
UBS RAISES BALFOUR BEATTY PRICE TARGET TO 260 (250) PENCE - 'SELL'
----------
UBS CUTS OXFORD INSTRUMENTS PRICE TARGET TO 1600 (1750) PENCE - 'BUY'
----------
CITIGROUP RAISES HIKMA PHARMACEUTICALS PRICE TARGET TO 1800 (1700) P. - 'BUY'
----------
JPMORGAN RAISES BODYCOTE PRICE TARGET TO 655 (540) PENCE - 'UNDERWEIGHT'
----------
JPMORGAN RAISES RPS GROUP PRICE TARGET TO 351 (341) PENCE - 'OVERWEIGHT'
----------
JPMORGAN CUTS REGUS PLC PRICE TARGET TO 174 (177) PENCE - 'UNDERWEIGHT'
----------
BERNSTEIN RAISES HOME RETAIL TO 'MARKET-PERFORM' ('UNDERPERFORM.') - PT 190 (140) PENCE.
----------
BARCLAYS INITIATES COMPUTACENTER WITH 'UNDERWEIGHT' - TARGET 600 PENCE
----------
JEFFERIES RAISES COMPUTACENTER PRICE TARGET TO 720 (470) PENCE - 'HOLD'
----------
MAIN MARKET AND AIM
----------
PANMURE RAISES HELLENIC CARRIERS PRICE TARGET TO 60 (50) PENCE - 'BUY'
----------
Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
17 Jan 2022 09:01

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 09:00

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 07:49

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

Read more
17 Jan 2022 07:08

Hikma buys Teligent Canadian assets for $47.75m

(Sharecast News) - Hikma Pharmaceuticals on Monday said it had agreed to buy the Canadian assets of Teligent for $45.75m after the US firm filed for Chapter 11 bankruptcy last year.

Read more
10 Jan 2022 07:44

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

Read more
10 Jan 2022 07:24

Hikma launches new US injectables unit

(Sharecast News) - Hikma Pharmaceuticals on Monday said it was expanding its injectables business with the launch of a new outsourced sterile compounding business in the US.

Read more
21 Dec 2021 15:55

Arecor flags milestone payment from Hikma in first half of next year

(Sharecast News) - Biopharmaceutical company Arecor Therapeutics updated the market on its ongoing exclusive agreement with Hikma Pharmaceuticals to co-develop a new, ready-to-use injectable medicine on Tuesday.

Read more
9 Dec 2021 09:25

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Read more
9 Dec 2021 08:32

Hikma strikes exclusive license agreement with Richter for denosumab

(Sharecast News) - Drugmaker Hikma Pharmaceuticals has entered into an exclusive license agreement with Gedeon Richter to commercialise the latter's denosumab products in the US.

Read more
4 Nov 2021 09:03

TOP NEWS: Hikma confirms 2021 guidance amid strong performance

TOP NEWS: Hikma confirms 2021 guidance amid strong performance

Read more
4 Nov 2021 07:58

Hikma reports solid trading in year to date

(Sharecast News) - Hikma Pharmaceuticals reiterated full-year guidance as the company reported solid trading across its business.

Read more
1 Nov 2021 13:52

Citi sees room for upside surprise on sales at Hikma Pharmaceuticals

(Sharecast News) - Analysts at Citi reiterated their 'buy' stance for shares of Hikma Pharmaceuticals ahead of the company's trading statement due out later in the same week.

Read more
28 Oct 2021 16:12

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
20 Oct 2021 09:51

LONDON BROKER RATINGS: BofA cuts Hammerson and upgrades Capco

LONDON BROKER RATINGS: BofA cuts Hammerson and upgrades Capco

Read more
27 Sep 2021 12:14

LONDON MARKET MIDDAY: Gains ebb; crunch time for US spending bills

LONDON MARKET MIDDAY: Gains ebb; crunch time for US spending bills

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.